子宫内膜异位症中雌、孕激素及其受体基因甲基化的研究进展

doi:10.12280/gjfckx.20220689

摘要/Abstract

摘要：

子宫内膜异位症（endometriosis，EMs）是育龄期女性的常见病及多发病，主要临床表现是痛经和不孕，复发率较高，并有潜在的恶变风险。EMs是雌激素依赖性疾病，具有孕酮抵抗特性，病灶局部雌、孕激素的合成及与受体的相互作用在EMs的发生和进展中起着十分重要的作用。局部高雌激素环境有利于异位内膜细胞的增殖、迁移、黏附和侵袭，促进EMs的发展甚至恶变；孕酮抵抗可影响子宫内膜容受性，与EMs相关性不孕密切相关。近年研究发现，DNA甲基化在EMs在位内膜和异位病灶雌、孕激素的合成及其受体表达过程中发挥重要的调控作用。了解雌、孕激素及其受体基因甲基化在EMs发生及发展、EMs相关性不孕和EMs恶变中的作用，可为EMs的诊断和药物靶向治疗研究提供依据。

关键词: 子宫内膜异位症, DNA甲基化, 雌激素类, 孕激素类, 受体, 雌激素, 受体, 孕酮

Abstract:

Endometriosis (EMs) is a common and frequent disease in women of reproductive age. The main clinical manifestations are dysmenorrhea and infertility, and there is a high recurrence rate and a potential risk of malignant transformation. EMs is an estrogen-dependent disease, with progesterone-resistant properties. The local synthesis of estrogen and progesterone in the ectopic lesions and the interactions with the receptors play an essential role in the development and progression of EMs. The local high estrogen environment favors the proliferation, migration, adhesion and invasion of ectopic endometrial cells, promoting the development of EMs and even malignancy. Progesterone resistance can affect endometrium tolerance and is closely associated with endometriosis-associated infertility. Recent studies have identified DNA methylation plays an important regulatory process in the synthesis of estrogen and progesterone and the expression of their receptors in eutopic endometrium and ectopic lesions of EMs. Understanding the role of gene methylation related to estrogen and progesterone and their receptors in the development of EMs, endometriosis-associated infertility and endometriosis-associated malignancy can provide a basis for diagnosis and drug-targeted therapy studies for EMs.

Key words: Endometriosis, DNA methylation, Estrogens, Progestins, Receptors, estrogen, Receptors, progesterone

王湘炼, 朱姝, 徐炜, 王秀丽. 子宫内膜异位症中雌、孕激素及其受体基因甲基化的研究进展[J]. 国际妇产科学杂志, 2023, 50(2): 165-169.

WANG Xiang-lian, ZHU Shu, XU Wei, WANG Xiu-li. Study on Methylation of Estrogen and Progesterone and Their Receptor Genes in Endometriosis[J]. Journal of International Obstetrics and Gynecology, 2023, 50(2): 165-169.

参考文献 34

[1]	International working group of AAGL, ESGE,ESHRE and WES,Tomassetti C, Tomassetti C, Johnson NP, et al. An International Terminology for Endometriosis, 2021[J]. J Minim Invasive Gynecol, 2021, 28(11):1849-1859. doi: 10.1016/j.jmig.2021.08.032. doi: 10.1016/j.jmig.2021.08.032
[2]	Vannuccini S, Clemenza S, Rossi M, et al. Hormonal treatments for endometriosis: The endocrine background[J]. Rev Endocr Metab Disord, 2022, 23(3):333-355. doi: 10.1007/s11154-021-09666-w. doi: 10.1007/s11154-021-09666-w
[3]	He J, Chang W, Feng C, et al. Endometriosis Malignant Transformation: Epigenetics as a Probable Mechanism in Ovarian Tumorigenesis[J]. Int J Genomics, 2018, 2018:1465348. doi: 10.1155/2018/1465348. doi: 10.1155/2018/1465348
[4]	Zubrzycka A, Zubrzycki M, Perdas E, et al. Genetic, Epigenetic, and Steroidogenic Modulation Mechanisms in Endometriosis[J]. J Clin Med, 2020, 9(5):1309. doi: 10.3390/jcm9051309. doi: 10.3390/jcm9051309
[5]	Retis-Resendiz AM, González-García IN, León-Juárez M, et al. The role of epigenetic mechanisms in the regulation of gene expression in the cyclical endometrium[J]. Clin Epigenetics, 2021, 13(1):116. doi: 10.1186/s13148-021-01103-8. doi: 10.1186/s13148-021-01103-8 pmid: 34034824
[6]	Izawa M, Taniguchi F, Harada T. GATA6 expression promoted by an active enhancer may become a molecular marker in endometriosis lesions[J]. Am J Reprod Immunol, 2019, 81(2):e13078. doi: 10.1111/aji.13078. doi: 10.1111/aji.13078
[7]	Barjaste N, Shahhoseini M, Afsharian P, et al. Genome-wide DNA methylation profiling in ectopic and eutopic of endometrial tissues[J]. J Assist Reprod Genet, 2019, 36(8):1743-1752. doi: 10.1007/s10815-019-01508-8. doi: 10.1007/s10815-019-01508-8
[8]	Dyson MT, Kakinuma T, Pavone ME, et al. Aberrant expression and localization of deoxyribonucleic acid methyltransferase 3B in endometriotic stromal cells[J]. Fertil Steril, 2015, 104(4):953-963.e2. doi: 10.1016/j.fertnstert.2015.06.046. doi: S0015-0282(15)00475-6 pmid: 26239024
[9]	Wang L, Zhao J, Li Y, et al. Genome-wide analysis of DNA methylation in endometriosis using Illumina Human Methylation 450 K BeadChips[J]. Mol Reprod Dev, 2019, 86(5):491-501. doi: 10.1002/mrd.23127. doi: 10.1002/mrd.23127
[10]	Mori T, Ito F, Koshiba A, et al. Local estrogen formation and its regulation in endometriosis[J]. Reprod Med Biol, 2019, 18(4):305-311. doi: 10.1002/rmb2.12285. doi: 10.1002/rmb2.12285 pmid: 31607790
[11]	Chantalat E, Valera MC, Vaysse C, et al. Estrogen Receptors and Endometriosis[J]. Int J Mol Sci, 2020, 21(8):2815. doi: 10.3390/ijms21082815. doi: 10.3390/ijms21082815
[12]	Hsiao KY, Wu MH, Tsai SJ. Epigenetic regulation of the pathological process in endometriosis[J]. Reprod Med Biol, 2017, 16(4):314-319. doi: 10.1002/rmb2.12047. doi: 10.1002/rmb2.12047
[13]	Xue Q, Xu Y, Yang H, et al. Methylation of a novel CpG island of intron 1 is associated with steroidogenic factor 1 expression in endometriotic stromal cells[J]. Reprod Sci, 2014, 21(3):395-400. doi: 10.1177/1933719113497283. doi: 10.1177/1933719113497283 pmid: 23899549
[14]	Bernardi LA, Dyson MT, Tokunaga H, et al. The Essential Role of GATA6 in the Activation of Estrogen Synthesis in Endometriosis[J]. Reprod Sci, 2019, 26(1):60-69. doi: 10.1177/1933719118756751. doi: 10.1177/1933719118756751 pmid: 29402198
[15]	Yamagata Y, Nishino K, Takaki E, et al. Genome-wide DNA methylation profiling in cultured eutopic and ectopic endometrial stromal cells[J]. PLoS One, 2014, 9(1):e83612. doi: 10.1371/journal. pone.0083612. doi: 10.1371/journal. pone
[16]	Chen H, Malentacchi F, Fambrini M, et al. Epigenetics of Estrogen and Progesterone Receptors in Endometriosis[J]. Reprod Sci, 2020, 27(11):1967-1974. doi: 10.1007/s43032-020-00226-2. doi: 10.1007/s43032-020-00226-2 pmid: 32700282
[17]	Marquardt RM, Kim TH, Shin JH, et al. Progesterone and Estrogen Signaling in the Endometrium: What Goes Wrong in Endometriosis?[J]. Int J Mol Sci, 2019, 20(15):3822. doi: 10.3390/ijms20153822. doi: 10.3390/ijms20153822
[18]	Xue Q, Lin Z, Cheng YH, et al. Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis[J]. Biol Reprod, 2007, 77(4):681-687. doi: 10.1095/biolreprod.107.061804. doi: 10.1095/biolreprod.107.061804 pmid: 17625110
[19]	Maekawa R, Mihara Y, Sato S, et al. Aberrant DNA methylation suppresses expression of estrogen receptor 1 (ESR1) in ovarian endometrioma[J]. J Ovarian Res, 2019, 12(1):14. doi: 10.1186/s13048-019-0489-1. doi: 10.1186/s13048-019-0489-1 pmid: 30728052
[20]	Todorow V, Rahmeh M, Hofmann S, et al. Promotor analysis of ESR1 in endometrial cancer cell lines, endometrial and endometriotic tissue[J]. Arch Gynecol Obstet, 2017, 296(2):269-276. doi: 10.1007/s00404-017-4405-x. doi: 10.1007/s00404-017-4405-x pmid: 28578502
[21]	Wu Y, Strawn E, Basir Z, et al. Promoter hypermethylation of progesterone receptor isoform B(PR-B) in endometriosis[J]. Epigenetics, 2006, 1(2):106-111. doi: 10.4161/epi.1.2.2766. doi: 10.4161/epi.1.2.2766
[22]	Rocha-Junior CV, Da Broi MG, Miranda-Furtado CL, et al. Progesterone Receptor B (PGR-B) Is Partially Methylated in Eutopic Endometrium From Infertile Women With Endometriosis[J]. Reprod Sci, 2019, 26(12):1568-1574. doi: 10.1177/1933719119828078. doi: 10.1177/1933719119828078 pmid: 30782101
[23]	Li Y, Adur MK, Kannan A, et al. Progesterone Alleviates Endometriosis via Inhibition of Uterine Cell Proliferation, Inflammation and Angiogenesis in an Immunocompetent Mouse Model[J]. PLoS One, 2016, 11(10):e0165347. doi: 10.1371/journal.pone.0165347. doi: 10.1371/journal.pone.0165347
[24]	Lessey BA, Kim JJ. Endometrial receptivity in the eutopic endometrium of women with endometriosis: it is affected, and let me show you why[J]. Fertil Steril, 2017, 108(1):19-27. doi: 10.1016/j.fertnstert.2017.05.031. doi: S0015-0282(17)30414-4 pmid: 28602477
[25]	Chi RA, Wang T, Adams N, et al. Human Endometrial Transcriptome and Progesterone Receptor Cistrome Reveal Important Pathways and Epithelial Regulators[J]. J Clin Endocrinol Metab, 2020, 105(4):e1419-e1439. doi: 10.1210/clinem/dgz117. doi: 10.1210/clinem/dgz117
[26]	Samadieh Y, Favaedi R, Ramezanali F, et al. Epigenetic Dynamics of HOXA10 Gene in Infertile Women With Endometriosis[J]. Reprod Sci, 2019, 26(1):88-96. doi: 10.1177/1933719118766255. doi: 10.1177/1933719118766255 pmid: 29592776
[27]	Mikhaleva LM, Davydov AI, Patsap OI, et al. Malignant Transformation and Associated Biomarkers of Ovarian Endometriosis: A Narrative Review[J]. Adv Ther, 2020, 37(6):2580-2603. doi: 10.1007/s12325-020-01363-5. doi: 10.1007/s12325-020-01363-5 pmid: 32385745
[28]	Andersen CL, Boisen MM, Sikora MJ, et al. The Evolution of Estrogen Receptor Signaling in the Progression of Endometriosis to Endometriosis-Associated Ovarian Cancer[J]. Horm Cancer, 2018, 9(6):399-407. doi: 10.1007/s12672-018-0350-9. doi: 10.1007/s12672-018-0350-9
[29]	Yamaguchi K, Huang Z, Matsumura N, et al. Epigenetic determinants of ovarian clear cell carcinoma biology[J]. Int J Cancer, 2014, 135(3):585-597. doi: 10.1002/ijc.28701. doi: 10.1002/ijc.28701 pmid: 24382740
[30]	Gaia-Oltean AI, Pop LA, Cojocneanu RM, et al. The shifting landscape of genetic alterations separating endometriosis and ovarian endometrioid carcinoma[J]. Am J Cancer Res, 2021, 11(4):1754-1769. pmid: 33948387
[31]	Guo C, Ren F, Wang D, et al. RUNX3 is inactivated by promoter hypermethylation in malignant transformation of ovarian endometriosis[J]. Oncol Rep, 2014, 32(6):2580-2588. doi: 10.3892/or.2014.3524. doi: 10.3892/or.2014.3524 pmid: 25333219
[32]	Wang D, Guo C, Li Y, et al. Oestrogen up-regulates DNMT1 and leads to the hypermethylation of RUNX3 in the malignant transformation of ovarian endometriosis[J]. Reprod Biomed Online, 2022, 44(1):27-37. doi: 10.1016/j.rbmo.2021.06.030. doi: 10.1016/j.rbmo.2021.06.030
[33]	Zhang H, Wu J, Li Y, et al. Identification of Key Differentially Methylated/Expressed Genes and Pathways for Ovarian Endometriosis by Bioinformatics Analysis[J]. Reprod Sci, 2022, 29(5):1630-1643. doi: 10.1007/s43032-021-00751-8. doi: 10.1007/s43032-021-00751-8
[34]	Houshdaran S, Oke AB, Fung JC, et al. Steroid hormones regulate genome-wide epigenetic programming and gene transcription in human endometrial cells with marked aberrancies in endometriosis[J]. PLoS Genet, 2020, 16(6):e1008601. doi: 10.1371/journal.pgen.1008601. doi: 10.1371/journal.pgen.1008601